Fig. 1 | Hypertension Research

Fig. 1

From: Impact of blood pressure variability on the prediction of cancer therapy-related cardiovascular toxicity in patients with multiple myeloma

Fig. 1The alternative text for this image may have been generated using AI.

Proposed mechanisms linking proteasome inhibitor treatment in multiple myeloma patients to increased blood pressure variability. Proteasome inhibitors may induce endothelial dysfunction, leading to increased arterial stiffness and alterations in the autonomic nervous system. In addition, multiple myeloma is also associated with autonomic dysfunction. These factors may contribute to the increased BPV. BPV, blood pressure variability

Back to article page